Solid biosciences to present at upcoming scientific conferences

Cambridge, mass., may 25, 2021 (globe newswire) -- solid biosciences inc. (nasdaq: sldb), a life sciences company focused on advancing meaningful therapies for duchenne muscular dystrophy (duchenne), today announced that the company will participate at the following upcoming scientific conferences:

SLDB Ratings Summary

SLDB Quant Ranking